Concepedia
Statistics
Publications
42
Citations
3.7K
H-Index
30
Active since
2001
Affiliations
Uppsala University(Current)
Lund University
Bristol-Myers Squibb (United States)
University Medical Center
Duke Medical Center
Ulrika Andersson is an author at Uppsala University specializing in medicine, cardiovascular disease, and public health.
Top concepts
MedicinePublic HealthCardiovascular DiseaseCardiologyThrombosisAtrial FibrillationAnesthesiologyMetabolismPhysiologyPharmacotherapy
Publications per year
2001–2022
Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation
Ziad Hijazi, Stefan H. Hohnloser, Jonas Oldgren et al. · Circulation · 2013 · 393 citations · Full text
Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation
Ziad Hijazi, Jonas Oldgren, Ulrika Andersson et al. · Circulation · 2012 · 392 citations
Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation
Lars Wallentin, Ziad Hijazi, Ulrika Andersson et al. · Circulation · 2014 · 300 citations
The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
Roopinder K. Sandhu, Justin A. Ezekowitz, Ulrika Andersson et al. · European Heart Journal · 2016 · 233 citations · Full text
N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation
Ziad Hijazi, Lars Wallentin, Agneta Siegbahn et al. · Journal of the American College of Cardiology · 2013 · 226 citations
Risk Assessment, Cardiovascular Disease, Pharmacology +7
1–5 of 42